| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute Ulceronecrotic Gastritis With Cytomegalovirus Reactivation: Uncommon Toxicity of Immune Checkpoint Inhibitors in Microsatellite Instability–High Metastatic Colorectal Cancer
|
Hulo, Pauline
|
|
|
19 |
4 |
p. e183-e188
|
artikel
|
| 2 |
Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)
|
Lapeyre-Prost, Alexandra
|
|
|
19 |
4 |
p. 285-290
|
artikel
|
| 3 |
Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism
|
Jácome, Alexandre A.
|
|
|
19 |
4 |
p. e189-e199
|
artikel
|
| 4 |
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial
|
Kasper, Stefan
|
|
|
19 |
4 |
p. 236-247.e6
|
artikel
|
| 5 |
Carcinoembryonic Antigen-related Tumor Kinetics After Eight Weeks of Chemotherapy is Independently Associated With Overall Survival in Patients With Metastatic Colorectal Cancer
|
Colloca, Giuseppe Antonio
|
|
|
19 |
4 |
p. e200-e207
|
artikel
|
| 6 |
Comment on Chun et al, “A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases”
|
Gelsomino, Fabio
|
|
|
19 |
4 |
p. e262-e263
|
artikel
|
| 7 |
Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer
|
Kim, Chan Wook
|
|
|
19 |
4 |
p. e157-e163
|
artikel
|
| 8 |
COVID-19: An Opportunity to Reimagine Colorectal Cancer Diagnostic Testing—A New Paradigm Shift
|
Nunoo-Mensah, Joseph W.
|
|
|
19 |
4 |
p. 227-230
|
artikel
|
| 9 |
Differences in Pathology and Mutation Status Among Colorectal Cancer Patients Younger Than, Older Than, and of Screening Age
|
Pereira, Allan A. Lima
|
|
|
19 |
4 |
p. e264-e271
|
artikel
|
| 10 |
Do We Have to Treat All T3 Rectal Cancer the Same Way?
|
Valadão, Marcus
|
|
|
19 |
4 |
p. 231-235
|
artikel
|
| 11 |
Economic Sustainability of Trifluridine/Tipiracil for the Treatment of Refractory Metastatic Colorectal Cancer in Real Life
|
Giuliani, Jacopo
|
|
|
19 |
4 |
p. e181-e182
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
19 |
4 |
p. A1
|
artikel
|
| 13 |
Effectiveness and Safety of Regorafenib vs. Trifluridine/Tipiracil in Unresectable Colorectal Cancer: A Retrospective Cohort Study
|
Nakashima, Masayuki
|
|
|
19 |
4 |
p. e208-e225
|
artikel
|
| 14 |
Effect of Exercise on Physical Function and Psychological Well-being in Older Patients With Colorectal Cancer Receiving Chemotherapy—A Systematic Review
|
Lund, Cecilia M.
|
|
|
19 |
4 |
p. e243-e257
|
artikel
|
| 15 |
Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer
|
Cortesi, Enrico
|
|
|
19 |
4 |
p. e272-e276
|
artikel
|
| 16 |
Eligibility of Real-World Patients With Stage II and III Colon Cancer for Adjuvant Chemotherapy Trials
|
Batra, Atul
|
|
|
19 |
4 |
p. e226-e234
|
artikel
|
| 17 |
FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall Survival
|
Jácome, Alexandre A.
|
|
|
19 |
4 |
p. 248-255.e6
|
artikel
|
| 18 |
Impact of Size and Location of Metastases on Early Tumor Shrinkage and Depth of Response in Patients With Metastatic Colorectal Cancer: Subgroup Findings of the Randomized, Open-Label Phase 3 Trial FIRE-3/AIO KRK-0306
|
Froelich, Matthias F.
|
|
|
19 |
4 |
p. 291-300.e5
|
artikel
|
| 19 |
Incidence of Asymptomatic Brain Metastases in Metastatic Colorectal Cancer
|
Shindorf, Mackenzie L.
|
|
|
19 |
4 |
p. 263-269
|
artikel
|
| 20 |
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer
|
Tosi, Federica
|
|
|
19 |
4 |
p. 256-262.e2
|
artikel
|
| 21 |
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer
|
Camera, Silvia
|
|
|
19 |
4 |
p. 311-318.e1
|
artikel
|
| 22 |
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial∗
|
Piccirillo, Maria Carmela
|
|
|
19 |
4 |
p. 270-276
|
artikel
|
| 23 |
Oxaliplatin and Methylprednisolone-induced Thrombocytopenia and Monocytopenia, Owing to Anti-GPIIbIIIa and -CD36 Antibodies in a Patient With Colorectal Cancer
|
Laurichesse, Mathieu
|
|
|
19 |
4 |
p. e277-e280
|
artikel
|
| 24 |
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts
|
Steffen, Thomas
|
|
|
19 |
4 |
p. 277-284
|
artikel
|
| 25 |
Severe Nonbacterial Thrombotic Endocarditis Resulting in Aortic Valve Insufficiency and Multiple Small Strokes in a Patient With Metastatic Pancreatic Cancer: Lessons for Optimal Management
|
Collienne, Maike
|
|
|
19 |
4 |
p. e258-e261
|
artikel
|
| 26 |
Skin Toxicities During Colorectal Cancer Chemotherapy: Incidence and Pearls of Treatment in Our Experience
|
Panariello, Luigia
|
|
|
19 |
4 |
p. e235-e242
|
artikel
|
| 27 |
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)
|
Samalin, Emmanuelle
|
|
|
19 |
4 |
p. 301-310.e1
|
artikel
|
| 28 |
Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis
|
Yaeger, Rona
|
|
|
19 |
4 |
p. e151-e156
|
artikel
|
| 29 |
Table of Contents
|
|
|
|
19 |
4 |
p. A3-A8
|
artikel
|
| 30 |
The Effects of Neoadjuvant Treatment on the Tumor Microenvironment in Rectal Cancer: Implications for Immune Activation and Therapy Response
|
Chen, Chien-Chih
|
|
|
19 |
4 |
p. e164-e180
|
artikel
|
| 31 |
Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
|
Fahmawi, Yazan
|
|
|
19 |
4 |
p. e281-e287
|
artikel
|
Tijdschrift beschrijving